Global Subcutaneous Immunoglobulins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Subcutaneous Immunoglobulins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Subcutaneous Immunoglobulins report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Subcutaneous Immunoglobulins market is projected to reach US$ 9807.2 million in 2034, increasing from US$ 4371.4 million in 2022, with the CAGR of 12.1% during the period of 2024 to 2034. Demand from Primary Immunodeficiency and Secondary Immunodeficiency are the major drivers for the industry.
In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.
South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.
In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Subcutaneous Immunoglobulins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Purity, Application and Regions Listed in the Report
Shire (Baxalta)
Grifols
CSL
Segment by Purity
0.1
0.2
Primary Immunodeficiency
Secondary Immunodeficiency
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Subcutaneous Immunoglobulins market further
Chapter 1Product Definition, Product Puritys, Volume and Revenue analysis of Each Purity in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Subcutaneous Immunoglobulins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Subcutaneous Immunoglobulins industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Subcutaneous Immunoglobulins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Subcutaneous Immunoglobulins introduction, etc. Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Subcutaneous Immunoglobulins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Subcutaneous Immunoglobulins report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Subcutaneous Immunoglobulins market is projected to reach US$ 9807.2 million in 2034, increasing from US$ 4371.4 million in 2022, with the CAGR of 12.1% during the period of 2024 to 2034. Demand from Primary Immunodeficiency and Secondary Immunodeficiency are the major drivers for the industry.
In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.
South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.
In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Subcutaneous Immunoglobulins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Purity, Application and Regions Listed in the Report
By Company
Shire (Baxalta)
Grifols
CSL
Segment by Purity
0.1
0.2
Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Subcutaneous Immunoglobulins market further
Chapter 1Product Definition, Product Puritys, Volume and Revenue analysis of Each Purity in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Subcutaneous Immunoglobulins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Subcutaneous Immunoglobulins industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Subcutaneous Immunoglobulins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Subcutaneous Immunoglobulins introduction, etc. Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Subcutaneous Immunoglobulins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices